Monopar Therapeutics Inc (MNPR)
Healthcare
Biotechnology
108.40 $
-5.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Monopar Therapeutics Inc (MNPR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -12 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.6 | -1.2 | -2.6 | -2.9 | -3.0 | -4.7 | -7.3 | -7.2 | -7.9 | -6.4 | -12 | |
| – | – | – | – | – | – | – | – | – | – | -716 | |
| – | – | 0.3 | 0.5 | 1.0 | 1.3 | 1.5 | 1.6 | 1.9 | 1.1 | 4.8 | |
| 14 | 14 | 14 | 0.5 | 1.0 | 1.2 | 1.5 | – | – | – | – | |
| 0.1 | 0.0 | 0.1 | -0.2 | 0.2 | 0.4 | 0.3 | 1.6 | -1.4 | 3.5 | -2.6 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | – | – | – | – | – | -4.9 | 4.9 | -14 | -63 | |
| – | 1.3 | 4.7 | – | 10 | 8.2 | 0.0 | 0.0 | 0.0 | 0.0 | -35 | |
| – | – | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | – | – | – | – | |
| 3.4 | 1.3 | 9.5 | -0.2 | 9.3 | 8.2 | 11 | 0.0 | 2.0 | 59 | 92 | |
| 2.8 | 0.1 | 6.9 | -2.9 | 6.3 | 3.5 | 3.6 | -12 | -0.9 | 39 | 16 | |
| -0.6 | -1.2 | -2.6 | -2.9 | -3.0 | -4.7 | -7.3 | -7.2 | -7.9 | -6.4 | -12 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.